Korea United Pharm (XKRX:033270) Cyclically Adjusted Book per Share: ₩23,089.77 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:033270 Korea United Pharm Inc XKRX:033270
90 GF Score
Price ₩17,910.00
GF Value ₩20,351.55
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Korea United Pharm Cyclically Adjusted Book per Share?

Korea United Pharm XKRX:033270 -1.38% 90 Cyclically Adjusted Book per Share is ₩23,089.77 as of Jun. 2026. GuruFocus rates XKRX:033270 with a GF Score™ of 90/100 and a GF Value™ of ₩20,351.55 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Korea United Pharm's adjusted book value per share for the three months ended in Jun. 2026 was ₩34,421.498. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩23,089.77 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Korea United Pharm's average Cyclically Adjusted Book Growth Rate was 11.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Korea United Pharm was 13.70% per year. The lowest was 11.00% per year. And the median was 12.50% per year.

As of today (2026-08-22), Korea United Pharm's current stock price is ₩17910.00. Korea United Pharm's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ₩23,089.77. Korea United Pharm's Cyclically Adjusted PB Ratio of today is 0.78.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Korea United Pharm was 8.25. The lowest was 0.74. And the median was 1.77.


Korea United Pharm  (XKRX:033270) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Korea United Pharm's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=17910.00/23089.77
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Korea United Pharm was 8.25. The lowest was 0.74. And the median was 1.77.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Korea United Pharm Cyclically Adjusted Book per Share Related Terms


Korea United Pharm Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Korea United Pharm's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Korea United Pharm Cyclically Adjusted Book per Share Chart

Korea United Pharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,184.88 15,907.69 17,852.27 19,702.31 21,770.26

Korea United Pharm Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20,706.98 21,235.91 21,770.26 22,366.79 23,089.77

XKRX:033270 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Korea United Pharm's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Korea United Pharm Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Korea United Pharm's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Korea United Pharm's Cyclically Adjusted PB Ratio falls into.


XKRX:033270
90GF Score
Korea United Pharm Inc XKRX:033270
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Korea United Pharm Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Korea United Pharm's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=34421.498/126.4904*126.4904
=34,421.498

Current CPI (Jun. 2026) = 126.4904.

Korea United Pharm Quarterly Data

Book Value per Share CPI Adj_Book
201609 11,755.597 101.461 14,655.555
201612 11,980.756 101.561 14,921.536
201703 12,063.210 102.851 14,835.891
201706 12,517.991 102.611 15,431.104
201709 13,241.849 103.491 16,184.739
201712 13,621.609 102.991 16,729.677
201803 13,865.896 104.101 16,848.120
201806 14,403.172 104.130 17,495.993
201809 14,895.739 105.651 17,833.971
201812 15,431.733 104.351 18,705.826
201903 15,729.153 104.491 19,040.767
201906 16,171.801 104.881 19,503.814
201909 16,784.126 105.200 20,180.844
201912 17,201.550 105.121 20,698.288
202003 17,658.876 105.354 21,201.606
202006 17,959.265 105.112 21,611.985
202009 18,496.662 106.198 22,031.102
202012 18,654.655 105.765 22,310.082
202103 18,928.808 107.357 22,302.300
202106 19,377.485 107.579 22,783.954
202109 20,112.876 108.759 23,391.913
202112 20,259.310 109.676 23,365.175
202203 20,701.653 111.848 23,411.776
202206 21,670.230 114.072 24,029.287
202209 23,286.352 114.715 25,676.610
202212 22,970.933 115.179 25,226.799
202303 23,567.033 116.507 25,586.387
202306 24,548.933 117.182 26,498.965
202309 25,706.875 118.964 27,333.343
202312 25,898.033 118.837 27,565.908
202403 26,712.357 120.123 28,128.261
202406 26,278.543 120.007 27,698.177
202409 26,635.382 120.861 27,875.945
202412 27,612.468 121.135 28,833.173
202503 28,029.064 122.590 28,920.854
202506 28,120.469 122.611 29,010.174
202509 29,210.974 123.402 29,942.114
202512 31,479.664 123.939 32,127.625
202603 28,949.502 125.236 29,239.469
202606 34,421.498 126.490 34,421.498

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₩23,089.77 mean?
Korea United Pharm (XKRX:033270) has a Cyclically Adjusted Book per Share of ₩23,089.77 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Korea United Pharm and its competitors.
Is Korea United Pharm's Cyclically Adjusted Book per Share too high?
Korea United Pharm's current Cyclically Adjusted Book per Share is ₩23,089.77. Overall, Korea United Pharm has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Korea United Pharm's Cyclically Adjusted Book per Share compare to ZTS?
Korea United Pharm's Cyclically Adjusted Book per Share of ₩23,089.77 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Korea United Pharm and its competitors. Korea United Pharm's current Cyclically Adjusted Book per Share is ₩23,089.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korea United Pharm stock overvalued right now?
Based on GuruFocus' analysis, Korea United Pharm (XKRX:033270) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩20,351.55, compared to a current price of ₩17,910.00 — trading 12% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₩23,089.77. Korea United Pharm's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Korea United Pharm (XKRX:033270), the current Cyclically Adjusted Book per Share is ₩23,089.77 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Korea United Pharm (XKRX:033270) Overvalued in 2026?

Based on GuruFocus' analysis, Korea United Pharm stock appears to be undervalued. The current stock price of ₩17,910.00 is trading 12% below its estimated GF Value™ of ₩20,351.55. GuruFocus considers Korea United Pharm to be Modestly Undervalued.

Key valuation signals for XKRX:033270:

  • Cyclically Adjusted Book per Share: ₩23,089.77
  • GF Value™: ₩20,351.55 vs. price of ₩17,910.00 (12% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the XKRX:033270 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Korea United Pharm Business Description

Address 404-10, Nojang-ri, Jeondong-myeon, Yeongi-gun, Chungnam, KOR, 339-840
Korea United Pharm Inc is a South Korea based company engages in the manufacture and distribution of pharmaceuticals and healthcare products. It offers incrementally modified drug, anti-cancer, prescription, and OTC products.
90GF Score

Get the complete analysis for XKRX:033270

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩17,910.00
Price
₩20,351.55
GF Value